KGC Sang-A to acquire Kyungnam Pharm

Published: 2003-09-08 06:57:00

Updated: 2003-09-08 06:57:00

The Korea Green Cross Sang-A Pharm said it has acquired 70 percent stake of Kyungnam Pharm for taking over the latter's managerial right and the remaining equities would be reserved to the existing Kyungnam's shareholders, adding that the acquisition fund would be financed by KGC Sang-A itself.
...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK